Filing Details
- Accession Number:
- 0001260616-10-000001
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-09-17 13:10:00
- Reporting Period:
- 2010-09-03
- Filing Date:
- 2010-09-17
- Accepted Time:
- 2010-09-17 13:10:00
- Original Submission Date:
- 2010-09-07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1405197 | Talecris Biotherapeutics Holdings Corp. | TLCR | Pharmaceutical Preparations (2834) | 202533768 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260616 | J Thomas Lynch | 79 Tw Alexander Drive 4101 Research Commons Research Triangle Park NC 27709 | Sr. Vp, Corp. Compliance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-09-03 | 131,929 | $22.50 | 2,631 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- The Reporting Person is amending the Form 4 filed on September 7, 2010 with respect to the September 3, 2010 disposition transaction reported in that Form 4, to correctly report that the number of shares disposed of was 131,929 shares instead of 113,440 shares.
- The number of shares reported consists of restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Billionaire Hedge Funds
